Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

Submitted by admin on August 26, 2020 - 10:56am
Source: 
Xconomy
News Tags: 
Acadia Pharmaceuticals
M&A
CerSci Therapeutics
post-surgical pain
nerve pain
Headline: 
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout
snippet: 

Acadia Pharmaceuticals has acquired Texas biotech CerSci Therapeutics, a privately held company with a clinical-stage molecule under evaluation as a potential therapy for post-surgical and nerve pain.

Do Not Allow Advertisers to Use My Personal information